BenzingaAugust 18, 2026 at 1:06 AM NY2 Months Ago

B of A Securities Initiates Coverage On Definium Therapeutics with Buy Rating, Announces Price Target of $75

DFTXDefinium Therapeutics Inc

B of A Securities analyst Tazeen Ahmad initiates coverage on Definium Therapeutics (NASDAQ:DFTX) with a Buy rating and announces Price Target of $75.

What This Story Means

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga